A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 1999
To determine the efficacy and safety of Sandostatin (octreotide) compared to placebo in controlling diarrhea which is a manifestation or complication of documented HIV infection and which is refractory (does not respond) to all known treatment classes.
Epistemonikos ID: 14ba9f4c7aa2cf3fe47acf8f7aa149767fbb4f42
First added on: Dec 01, 2021